Next Article in Journal
A Systematic Review of Vitamin D during Pregnancy and Postnatally and Symptoms of Depression in the Antenatal and Postpartum Period from Randomized Controlled Trials and Observational Studies
Previous Article in Journal
Effects of an Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety, and Gut Microbiome in Infants with Cow’s Milk Protein Allergy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 11
10.3390/nu14112301
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association of Serum 25(OH)D with Metabolic Syndrome in Chinese Women of Childbearing Age

by
Xiaoyun Shan
,
Xiayu Zhao
,
Siran Li
,
Pengkun Song
,
Qingqing Man
,
Zhen Liu
,
Yichun Hu
and
Lichen Yang
*
Key Laboratory of Trace Element Nutrition of National Health Committee, National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(11), 2301; https://doi.org/10.3390/nu14112301
Submission received: 25 April 2022 / Revised: 27 May 2022 / Accepted: 28 May 2022 / Published: 30 May 2022
(This article belongs to the Section Micronutrients and Human Health)
Review Reports Versions Notes

Abstract

:
Objective: To analyze the associations between serum 25(OH)D levels and the risk of metabolic syndrome (MetS) and its components, and the related genetic and non-genetic factors in non-diabetic women of childbearing age in China. Methods: Subjects were randomly selected from the 2015 Chinese Adult Chronic Disease and Nutrition Surveillance. The data of sociodemographic characteristics and lifestyle factors were obtained through questionnaire survey. Anthropometry was measured by trained interviewers, and fasting blood was collected to test 25-hydroxyvitamin D [25(OH)D], total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), fasting blood glucose (FBG), and other related parameters. Generalized linear mode and multivariate logistic analysis were performed to analyze the associations between serum 25(OH)D and MetS and its components, adjusting for the possible confounders. Results: Body mass index (BMI), serum alanine aminotransferase (ALT), hypersensitive C-reactive protein (hs-CRP), 25(OH)D, phosphorus (P), and parathyroid hormone (PTH) levels were associated with the number of MetS’s components. G allele carriers of GC rs2282679 had higher diastolic blood pressure (DBP) and FBG levels compared with the TT genotypes, while higher genetic risk score (GRS) seemed to be associated with reduced HDL-C level. The odds ratio (OR) for MetS in lowest group of 25(OH)D was 1.533 (0.980–2.399) after adjusting for season, district, area type, latitude, age, BMI, PTH, P, ALT, CRE, interleukin-6 (IL-6), and hs-CRP, compared with the median group, but the association was not significant. An insufficient 25(OH)D concentration (<14.22 ng/mL) was significantly related to the risk of elevated waist circumference (WC) (OR = 1.612 (1.014–2.561)) and TG (OR = 2.210 (1.318–3.706)), and reduced HDL-C (OR = 1.639 (1.206–2.229)) after adjusting for the confounders among these women. Moreover, these relationships were not affected by vitamin D metabolism-related gene polymorphisms. Conclusion: After comprehensively considering various influencing factors, significant associations between insufficient serum 25(OH)D and MetS‘s components, including elevated WC, TG, and reduced HDL-C, were observed. However, MetS, hypertension, and hyperglycemia were not found independently associated with 25(OH)D levels.

1. Introduction

Vitamin D, a fat-soluble prohormone, exerts crucial roles in maintaining bone health and calcium homeostasis [1]. 25-hydroxyvitamin D [25(OH)D], the main form of circulating vitamin D, is widely applied as an indicator of vitamin D status. It is now well demonstrated that vitamin D also plays a role in many extra-skeletal health issues [2], such as metabolic syndrome (MetS) [3,4], type 2 diabetes mellitus (T2DM) [5], abdominal obesity [6,7], hypertension [8,9], and dyslipidemia [10].
MetS, a complex of metabolic abnormalities, is characterized by abdominal obesity, hypertension, hyperlipidemia, and elevated serum glucose [11]. Epidemiological evidence shows that, MetS is the risk factor of T2DM [12], cardiovascular disease (CVD) [13], kidney disease [14], and cancer [15]. It has been estimated by International Diabetes Federation (IDF) that one-quarter of the world’s population has MetS [16]. MetS is common in China as well, with prevalence of MetS increasing with age from 3.60% to 21.68% [17]. Therefore, MetS has attracted more and more attention in the field of public health.
Recently, many epidemiological studies are focusing on the association between vitamin D and MetS, but the results were inconsistent. For instance, a Japanese study suggested that higher 25(OH)D levels were associated with decreased risk of MetS among adults, but there were no statistically significant associations between 25(OH)D and each component of MetS after adjustment [18]. Similarly, a cross-sectional study for non-diabetic young adults in Northern Taiwan showed an inverse association of vitamin D status with MetS and its individual components, but body mass index (BMI) and homeostasis model assessment of insulin resistance (HOMA-IR) could largely remove the association [19]. Similar studies have also been carried out in the Chinese Mainland. A study for middle-aged men in Dalian in northeast China reported that decreased serum 25(OH)D level was significantly correlated with MetS [20]. In Shanghai, women without MetS were found to have significantly higher 25(OH)D level than those with MetS, but no such difference was observed for men [21]. Data based on the Chinese Longitudinal Healthy Longevity Survey (CLHLS) showed that higher serum vitamin D concentrations were associated with a lower prevalence of MetS, but the association was only statistically significant among old people with noncentral obesity [22]. Taken together, there is a lack of conclusive evidence for the Chinese population, especially for young women, to demonstrate the association between serum 25(OH)D levels and MetS [23]. Additionally, most of these studies did not consider the comprehensive effects of genetic factors, hepatic and renal function, inflammatory status, and other factors.
Thus, in the present study, we collected data from the 2015 Chinese Chronic Diseases and Nutrition Survey (CCDNS) and measured the relevant clinical parameters. We aimed to evaluate the independent association between serum 25(OH)D and the risk of MetS and its components, and analyze the related genetic and non-genetic factors, among Chinese childbearing aged women who were not diagnosed with diabetes.

2. Materials and Methods

2.1. Subjects

In this study, women of childbearing age were randomly selected from the 2015 CCDNS sample bank, according to the sampling method described in our previous reports [24]. We excluded the samples with diabetes, missing information, poor blood quality (hemolysis), and biological index values below or above the detection limit. Thus, a total of 1505 women were finally included in this study. Written informed consent was obtained from every participant. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the National Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention (file number 201519-A).

2.2. Data Collection and Variable Classifications

The data of sociodemographic characteristics (age, nationality, and education) and lifestyle factors (cigarette smoking and alcohol consuming) were obtained by professional interviewers through questionnaire survey. The education level was divided into primary (primary school and below), medium (junior middle school/Senior High School), and advanced (junior college and above). Cigarette smoking status was divided into never and current/former smoker. If participants had a history of alcohol intake in the past year, they were classified as alcohol consumers. Height, weight, waist circumference (WC), and blood pressure (BP) including systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured by trained interviewers. BP was measured three times, and the average was used in the analysis. BMI was calculated as weight (kg) divided by height squared (m2). BMI levels were categorized as underweight (<18.5 kg/m2), normal weight (18.5–23.9 kg/m2), overweight (24.0–27.9 kg/m2), or obese (≥28.0 kg/m2) based on Chinese criteria [25].

2.3. Laboratory Measurements

Fasting venous blood (10 mL) was drawn from each participant and centrifuged and separated into plasma, serum, and red blood cells, and then stored at −80 °C in freezers until analysis. All blood samples were analyzed in strict accordance with the manufacturer’s protocol and standard laboratory test methods. Serum 25(OH)D was measured by the liquid chromatography-tandem mass spectroscopy (LC-MS/MS) (AB Sciex Pte. Ltd., Framingham, MA, USA). Parathyroid hormone (PTH) and interleukin-6 (IL-6) were measured by electronic chemiluminescence immunoassay (Roche e601, F Hoffmann-La Roche Ltd., CH4002, Basel, Switzerland). Serum fasting blood glucose (FBG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglyceride (TG) were measured using an automatic biochemical analyzer (Hitachi 7600, Tokyo, Japan). Serum calcium (Ca) was detected by inductively coupled plasma mass spectrometry (ICP-MS, PerkinElmer, NexION 350, Waltham, MA, USA). In addition, serum phosphorus (P), creatinine (CRE), alanine aminotransferase (ALT), hypersensitive C-reactive protein (hs-CRP) was detected by using a Hitachi 7600-210 ISE automatic biochemistry analyzer (Hitachi 7600, Japan).

2.4. Definitions of MetS

According to the 2017 version of the Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (the 2017 version) and a joint multinational interim statement [26], MetS was diagnosed when there were three or more of the following components: WC > 85 cm; serum TG concentration > 1.7 mmol/L or with treatment for the lipid abnormality; HDL-C concentration < 1.3 mmol/L or with treatment; BP ≥ 130/85 mmHg or with treatment; or serum FBG concentration ≥ 5.6 mmol/L or previously diagnosed with T2DM.

2.5. SNP Selection and Detection

Based on the findings from previous studies [27,28,29], vitamin D metabolism relatedsingle nucleotide polymorphisms (SNPs), such as cytochrome P450-2R1 (CYP2R1) rs12794714, VDBP (GC) rs2282679, and vitamin D receptor (VDR) rs2228570 were selected. The SNPs selected were all in accordance with Hardy– Weinberg equilibrium (secondary allele frequency (MAF) > 0.1, Table S1). The SNPs were detected by the improved multiple ligase detection reaction (iMLDR). A genetic risk score (GRS) for 25(OH)D was the sum of the number of A alleles of rs12794714, T alleles of rs2282679, and G alleles of rs2228570 (range from 0 to 6).

2.6. Statistical Analysis

All data management and statistical analyses were performed with IBM SPSS Statistics 23. Non-normally distributed continuous variables were described as medians and interquartile ranges (P25 and P75). Non-parametric statistics were used when comparing continuous variables between groups. Categorical variables were described as percentages and compared by using the chi-squared test. Associations between serum 25(OH)D and risk factors of MetS components, Ca, P, PTH, ALT, CRE, and other factors were analyzed by using the generalized linear mode. Participants were categorized into 3 levels according to our previous study [24], and the median level (14.22–18.06 ng/mL) was taken as the reference. Multivariate logistic analysis was applied to analyze the relationship between serum 25(OH)D status and risk of MetS as well as its components. The crude model was not adjusted. The adjusted model was adjusted for season, district, area type, latitude, age, BMI, PTH, P, ALT, CRE, IL-6, hs-CRP, with or without GRS. p < 0.05 was considered statistically significant.

3. Results

3.1. Characteristics of the Studied Population

A total of 1505 participants were included in this study, and their sociodemographic characteristics, lifestyle factors and SNPs were shown in Table 1.

3.2. Clinical Characteristics According to the Number of MetS’s Components

As the number of MetS components increased, there was a significantly positive association observed in BMI, WC, BP, PTH, ALT, hs-CRP, TG, LDL-C, and FBG (p < 0.05 for trend). On the contrary, a significant inverse association was noted between P and HDL-C and the MetS components. When the one or more components appeared, 25(OH)D decreased significantly. However, with the increase of MetS components, the trends of serum Ca, CRE, and IL-6 were not statistically significant (Table 2).

3.3. Relationships of Vitamin D Related SNPs and the MetS’s Components

As shown in Table 3, subjects with genotypes GG and GT of rs2282679 polymorphism had significantly lower levels of 25(OH)D and higher levels of DBP and FBG, compared to genotype TT carriers. Additionally, the GG carriers of rs2228570 (FokI) had lower 25(OH)D levels among this population. Moreover, significantly lower 25(OH)D and HDL-C level in subjects with GRS between 4–6 was observed. However, there were no differences in these parameters between rs12794714 genotypes.

3.4. Linear Relationships between Serum 25(OH)D and Risk Factors of MetS and Other Related Factors

The generalized linear model showed the partial correlation coefficients between serum 25(OH)D and the indicators of MetS and the other related factors (Table 4). Overall, 25(OH)D was positively associated with BMI and FBG. In addition, season, district, area type, GRS, latitude, age, PTH, CRE, IL-6, and hs-CRP were also independent influencing factors of vitamin D levels. However, no statistically significant correlations between 25(OH)D and other factors, including Ca, P, ALT, WC, TC, TG, LDL-C, HDL-C, and BP, were found.

3.5. Associations between BMI, MetS’s Components and Vitamin D Insufficiency

Just as shown in Table 5, vitamin D insufficiency was defined as 25(OH)D < 14.22 ng/mL according to our previous results [24], and a total of 358 (23.79%) women recruited had MetS. Participants with elevated TG and reduced HDL-C were found to have higher prevalence of vitamin D insufficiency (p < 0.05), but participants with hyperglycemia were more prone to vitamin D sufficiency (p < 0.05). The other components and BMI levels were not shown to be associated with vitamin D insufficiency (p > 0.05).

3.6. Odds Ratios for MetS and Its Components in Different Levels of Vitamin D

The results of the multivariate logistic analysis of the associations between serum 25(OH)D status and the incidents of MetS and its components are summarized in Table 6. The adjusted models were adjusted for season, district, area type, latitude, age, BMI, PTH, P, ALT, CRE, IL-6, hs-CRP, or GRS, which had been shown to be related to vitamin D or MetS. In the crude model, there were no associations between the vitamin D status and incidents of MetS, elevated waist, hypertension, and hyperglycemia. However, a U-shape trend was observed between serum vitamin D levels and elevated TG (p1 = 0.002, p2 = 0.042). After adjustments, the ORs and 95% CI for elevated WC, elevated TG, and reduced HDL-C comparing the lowest level (<14.22 ng/mL) versus the middle level (14.22–18.06 ng/mL) of serum 25(OH)D was 1.612 (1.014–2.561), 2.210 (1.318–3.706), 1.639 (1.206–2.229), respectively. No significant associations were observed between 25(OH)D levels and the incidence of MetS, hypertension, and hyperglycemia, even after adjusting for the confounding factors. Adjusting for GRS or not had no effects on these associations.

4. Discussion

Vitamin D deficiency is very common in female adults between 18–44 years old in China [30], and the prevalence of MetS in Chinese women aged ≥15 years old is high, reaching to 27.0% [31]. Thus, in this study, we analyzed the association between serum 25(OH)D and MetS and its components and explored the related factors for Chinese women of childbearing age (18–44 years old) based on the 2015 CCDNS.
In evaluating the association between vitamin D and MetS, we primarily analyzed the genetic and non-genetic factors that may be related to vitamin D or MetS. Though the exact underlying etiology of MetS and its components is still not well demonstrated, insulin resistance, obesity, adipose tissue dysfunction, proinflammatory states, and genetic factors are generally considered to be the contributing factors [32,33]. In our study, we also found that the BMI and hs-CRP increased significantly with the accumulation of MetS’s components. As vitamin D can be sequestered in adipose tissue, especially in obese individuals, and vitamin D deficiency can inhibit β cells from converting pro-insulin into insulin [34,35], the observed associations between vitamin D as well as its related factors, such as serum P, and MetS’s components in our study can be well understood. Moreover, experimental evidence suggests that adipose tissue, the arterial vascular wall, cardiac muscle cells, and adrenal cortex cells may be the non-classical target organs of PTH. This is why PTH may play roles in regulating body energy, blood pressure, and metabolism [36]. As found in our study, PTH was significantly higher in the group containing ≥1 components of MetS. In addition, studies estimate that a certain proportion of some individual MetS components and the collective MetS phenotype is attributed to genetic heritability [37], and some studies have reported the relationship between vitamin D metabolism-related polymorphisms and MetS. For example, Oh, JY, and Barrett-Connor, E found that the bb genotype of BsmI VDR polymorphism was associated with insulin resistance after adjustment for age, sex, BMI, and Ca and vitamin D use in a Caucasian population without diabetes [38]. Another study from Wroclaw also found that the BsmI VDR polymorphism was able to influence BMI and WC, while the FokI (rs2228570) VDR polymorphism appeared to affect insulin sensitivity and serum HDL-C level [39]. Moreover, individuals without MetS and with heterozygosis for FokI C > T presented higher concentration of TG and lower HDL-C than those without this polymorphism [40]. In addition, GC polymorphisms, such as rs2282679 and rs4588, were also shown to be associated with MetS susceptibility among the Chinese rural population, which might be through regulating the blood lipid (TG and HDL-C) levels [41]. In our study, rs2282679 was found to affect DBP and FBG. Then, we comprehensively considered the effects of three key gene polymorphisms, CYP2R1 rs12794714, GC rs2282679, and VDR rs2228570, which have been demonstrated to be related with vitamin D levels or distributions, by calculating GRS. GRS was found to be related to lower HDL-C. Moreover, in the linear regression analysis, season, district, area type, GRS, latitude, age, BMI, PTH, P, CRE, IL-6. and hs-CRP were independently associated with serum 25(OH)D. Thus, we intended to include these factors as confounders in assessing the associations between vitamin D and the risk of MetS and its components.
At present, a large number of epidemiological studies have explored the associations between vitamin D and MetS for different populations. Primarily, cross-sectional studies from different countries have shown the inverse relationship between vitamin D levels and the risk of developing MetS [20,42,43]. However, in Berlin, the independent inverse associations between vitamin D insufficiency and MetS among older adults without diabetes, could be removed by BMI [44]. Similarly, among non-diabetic young adults in Taiwan, the OR of having MetS was negatively associated with vitamin D levels after adjusting for age and sex. However, obesity and insulin resistance could affect the association [19]. In addition, longitudinal studies have also been published on the relationship between serum vitamin D levels and MetS risk, which also showed inconsistent conclusions [45,46,47,48]. However, a systematic review and meta-analysis of prospective studies concluded that vitamin D status at baseline in apparently healthy adults was inversely associated with future risks of T2DM and MetS [49]. In addition, a dose-response meta-analysis of cross-sectional studies and cohort studies among adults demonstrated that a 25 nmol/L (or 10 ng/mL) increment in the serum 25(OH)D concentration was associated with 20% and 15% lower risks of MetS, respectively [4]. Additionally, in postmenopausal women with VD deficiency, supplementation with 1000 international unit (IU) vitamin D3 alone for 9 months was associated with a reduction in the MetS risk profile [50]. In this cross-sectional study, to better assess the relationship of vitamin D and MetS, we firstly compared the prevalence of vitamin D insufficiency in subjects with or without MetS or its components. Women with elevated TG and reduced HDL-C turned out to have a higher prevalence of vitamin D insufficiency, which could be well-supported by the current theories. Then, we comprehensively considered the meaningful genetic and non-genetic factors related to vitamin D and MetS. We also found that vitamin D insufficiency resulted in about a 1.5-fold increase in the risk of MetS. However, the association was not statistically significant, which might be related to the interactions between different factors.
With regard to the relationships between vitamin D and the components of MetS, the findings from different studies were inconsistent, which may be related to race, age, and the confounders considered in the data analyses. The Furukawa Nutrition and Health Study among Japanese adults suggested that there was inverse but non-significant associations between 25(OH)D and each component of MetS [18]. The CLHLS for the elderly in 2017 indicated that adequate vitamin D levels were protective factors for elevated TG and reduced HDL-C after adjustments for other components. However, no significant association was found between vitamin D deficiency and elevated WC [22]. A cross-sectional study, conducted in Wuhan City, China, also observed significant inverse relationships between 25(OH)D and elevated TG, reduced HDL-C, and elevated BP, but not others [51]. Interestingly, for the American participants, a significant inverse relationship was observed between HDL-C and 1,25(OH)2D, but not 25(OH)D, suggesting that the active form of vitamin D, 1,25(OH)2D, might play a role in metabolic regulation [42]. A follow-up study conducted among healthy adolescent girls in Iran reported that there were significant reductions in DBP, WC, and serum FBG, TC, and LDL-C after the 9-week vitamin D supplementation, but no significant effects were observed on BMI, SBP, serum HDL-C, or TG [52]. Moreover, a recent meta-analysis including nine cross-sectional studies indicated that abdominal obesity, high BP, high TG, and reduced HDL-C were statistically associated with vitamin D status in the female population [53]. In our study, elevated WC and TG and reduced HDL-C were associated with insufficient vitamin D among women of childbearing age. No associations between vitamin D and hypertension and hyperglycemia were observed. Similar to MetS, the associations between MetS’s components and vitamin D were not found to be influenced by GRS. Of course, to verify these conclusions, case-control, cohort studies, and randomized controlled trials are needed in the future.
As this study was based on a nationally cross-sectional survey, it could well represent the current status of women of childbearing age in China. Additionally, questionnaire investigation, body measurements, blood samples collection, and laboratory measurements in the study were conducted in strict accordance with the procedures. The associations between vitamin D and MetS and its components were analyzed after adjusting for possible confounders, including season, district, area type, latitude, age, BMI, PTH, P, ALT, CRE, IL-6, hs-CRP, or GRS. Meanwhile, some limitations should also be noted. We did not include the dietary vitamin D and Ca intake to evaluate the association between 25(OH)D and incidence of the MetS. In addition, as this is a cross-sectional study, the causal relationship between vitamin D and metabolic syndrome and its components cannot be well-verified. Moreover, some other confounding information such as exercise and history of disease was not collected. Thus, further studies should be conducted to infer causality effectively, and investigate the pathophysiologic mechanisms of vitamin D for predicting MetS and other metabolic diseases.

5. Conclusions

The present cross-sectional study suggested that serum 25(OH)D, P, PTH, and some other common risk factors levels were associated with the number of MetS components in women of childbearing age. DBP and FBG were found to be related to GC rs2282679, while HDL-C was related to GRS. Serum 25(OH)D level was linearly correlated with BMI and FBG. In addition, we used the threshold established in our previous study to analyze the association of vitamin D and MetS. After adjustment for the possible confounders in the multivariate logistic analysis, lower 25(OH)D level (<14.22 ng/mL) was found to increase the risk of MetS’s components, including elevated WC, TG, and reduced HDL-C. However, no significant association was found between 25(OH)D levels and risk of MetS, hypertension, and hyperglycemia. Furthermore, GRS had no impact on the results of MetS risk assessment.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/nu14112301/s1, Table S1: Hardy–Weinberg testing results of vitamin D metabolism related gene polymorphisms.

Author Contributions

Formal analysis, writing—original draft preparation, writing—review and editing, X.S.; methodology, X.S., X.Z. and S.L.; software, X.Z.; resources, P.S. and Q.M.; investigation, Z.L.; validation and data curation, Y.H.; conceptualization, visualization, supervision, project administration, and funding acquisition, L.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by the National Natural Science Foundation of China (No. 81872627).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Review Committee of Chinese Center for Disease Control and Prevention (file number 201519-A).

Informed Consent Statement

Written informed consent has been obtained from all subjects involved in the study to publish this paper.

Acknowledgments

We would like to thank every participant joining the survey. We also sincerely appreciate the dedication of each colleague from the 2015 Chinese Adult Chronic Disease and Nutrition Surveillance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Saponaro, F.; Saba, A.; Zucchi, R. An Update on Vitamin D Metabolism. Int. J. Mol. Sci. 2020, 21, 6573. [Google Scholar] [CrossRef]
  2. Marino, R.; Misra, M. Extra-Skeletal Effects of Vitamin D. Nutrients 2019, 11, 1460. [Google Scholar] [CrossRef] [Green Version]
  3. Mutt, S.J.; Jokelainen, J.; Sebert, S.; Auvinen, J.; Jarvelin, M.R.; Keinanen-Kiukaanniemi, S.; Herzig, K.H. Vitamin D Status and Components of Metabolic Syndrome in Older Subjects from Northern Finland (Latitude 65 degrees North). Nutrients 2019, 11, 1229. [Google Scholar] [CrossRef] [Green Version]
  4. Lee, K.; Kim, J. Serum vitamin D status and metabolic syndrome: A systematic review and dose-response meta-analysis. Nutr. Res. Pract. 2021, 15, 329–345. [Google Scholar] [CrossRef]
  5. Mohammadi, S.; Hajhashemy, Z.; Saneei, P. Serum vitamin D levels in relation to type-2 diabetes and prediabetes in adults: A systematic review and dose-response meta-analysis of epidemiologic studies. Crit. Rev. Food Sci. Nutr. 2021, 1–21. [Google Scholar] [CrossRef]
  6. Hajhashemy, Z.; Foshati, S.; Saneei, P. Relationship between abdominal obesity (based on waist circumference) and serum vitamin D levels: A systematic review and meta-analysis of epidemiologic studies. Nutr. Rev. 2021, 80, 1105–1117. [Google Scholar] [CrossRef]
  7. Hajhashemy, Z.; Shahdadian, F.; Ziaei, R.; Saneei, P. Serum vitamin D levels in relation to abdominal obesity: A systematic review and dose-response meta-analysis of epidemiologic studies. Obes Rev. 2021, 22, e13134. [Google Scholar] [CrossRef]
  8. Qi, D.; Nie, X.L.; Wu, S.; Cai, J. Vitamin D and hypertension: Prospective study and meta-analysis. PLoS ONE 2017, 12, e0174298. [Google Scholar] [CrossRef] [Green Version]
  9. Shen, Q.; Xu, Q.; Li, G.; Ren, L.; Zhang, Z.; Zhang, Y.; Zhong, Z.; Li, X.; Wang, Q. Joint effect of 25-hydroxyvitamin D and secondhand smoke exposure on hypertension in non-smoking women of childbearing age: NHANES 2007–2014. Environ. Health 2021, 20, 117. [Google Scholar] [CrossRef]
  10. Kelishadi, R.; Farajzadegan, Z.; Bahreynian, M. Association between vitamin D status and lipid profile in children and adolescents: A systematic review and meta-analysis. Int. J. Food Sci. Nutr. 2014, 65, 404–410. [Google Scholar] [CrossRef]
  11. Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens Rep. 2018, 20, 12. [Google Scholar] [CrossRef] [Green Version]
  12. Bellou, V.; Belbasis, L.; Tzoulaki, I.; Evangelou, E. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS ONE 2018, 13, e0194127. [Google Scholar] [CrossRef]
  13. Mottillo, S.; Filion, K.B.; Genest, J.; Joseph, L.; Pilote, L.; Poirier, P.; Rinfret, S.; Schiffrin, E.L.; Eisenberg, M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56, 1113–1132. [Google Scholar] [CrossRef] [Green Version]
  14. Thomas, G.; Sehgal, A.R.; Kashyap, S.R.; Srinivas, T.R.; Kirwan, J.P.; Navaneethan, S.D. Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 2011, 6, 2364–2373. [Google Scholar] [CrossRef] [Green Version]
  15. Esposito, K.; Chiodini, P.; Colao, A.; Lenzi, A.; Giugliano, D. Metabolic syndrome and risk of cancer: A systematic review and meta-analysis. Diabetes Care 2012, 35, 2402–2411. [Google Scholar] [CrossRef] [Green Version]
  16. O’Neill, S.; O’Driscoll, L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015, 16, 1–12. [Google Scholar] [CrossRef] [Green Version]
  17. Qin, X.; Qiu, L.; Tang, G.; Tsoi, M.F.; Xu, T.; Zhang, L.; Qi, Z.; Zhu, G.; Cheung, B.M.Y. Prevalence of metabolic syndrome among ethnic groups in China. BMC Public Health 2020, 20, 297. [Google Scholar] [CrossRef]
  18. Akter, S.; Eguchi, M.; Kurotani, K.; Kochi, T.; Kashino, I.; Ito, R.; Kuwahara, K.; Tsuruoka, H.; Kabe, I.; Mizoue, T. Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population: The Furukawa Nutrition and Health Study. Nutrition 2017, 36, 26–32. [Google Scholar] [CrossRef]
  19. Huang, C.Y.; Chang, H.H.; Lu, C.W.; Tseng, F.Y.; Lee, L.T.; Huang, K.C. Vitamin D status and risk of metabolic syndrome among non-diabetic young adults. Clin. Nutr. 2015, 34, 484–489. [Google Scholar] [CrossRef]
  20. Weldegiorgis, T.Z.; Hidru, T.H.; Yang, X.L.; Xia, Y.L.; Ma, L.; Li, H.H. Association between serum 25-hydroxyvitamin D concentrations and metabolic syndrome in the middle-aged and elderly Chinese population in Dalian, northeast China: A cross-sectional study. J. Diabetes Investig. 2020, 11, 184–191. [Google Scholar] [CrossRef] [Green Version]
  21. Zhu, W.; Heil, D.P. Associations of vitamin D status with markers of metabolic health: A community-based study in Shanghai, China. Diabetes Metab. Syndr. 2018, 12, 727–732. [Google Scholar] [CrossRef] [Green Version]
  22. Liu, L.; Cao, Z.; Lu, F.; Liu, Y.; Lv, Y.; Qu, Y.; Gu, H.; Li, C.; Cai, J.; Ji, S.; et al. Vitamin D deficiency and metabolic syndrome in elderly Chinese individuals: Evidence from CLHLS. Nutr. Metab. 2020, 17, 58. [Google Scholar] [CrossRef]
  23. Wimalawansa, S.J. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J. Steroid. Biochem. Mol. Biol. 2018, 175, 177–189. [Google Scholar] [CrossRef]
  24. Hu, Y.; Li, S.; Wang, J.; Zheng, D.; Zhang, H.; Yu, W.; Zhu, L.; Liu, Z.; Yang, X.; Yang, L. Threshold for Relationship between Vitamin D and Parathyroid Hormone in Chinese Women of Childbearing Age. Int. J. Environ. Res. Public Health 2021, 18, 13060. [Google Scholar] [CrossRef]
  25. Zhou, B.F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 2002, 15, 83–96. [Google Scholar]
  26. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C., Jr.; et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [Google Scholar] [CrossRef] [Green Version]
  27. Lu, L.; Sheng, H.; Li, H.; Gan, W.; Liu, C.; Zhu, J.; Loos, R.J.; Lin, X. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Hum. Genet. 2012, 131, 505–512. [Google Scholar] [CrossRef]
  28. Arabi, A.; Khoueiry-Zgheib, N.; Awada, Z.; Mahfouz, R.; Al-Shaar, L.; Hoteit, M.; Rahme, M.; Baddoura, R.; Halabi, G.; Singh, R.; et al. CYP2R1 polymorphisms are important modulators of circulating 25-hydroxyvitamin D levels in elderly females with vitamin insufficiency, but not of the response to vitamin D supplementation. Osteoporos Int. 2017, 28, 279–290. [Google Scholar] [CrossRef]
  29. Yao, P.; Sun, L.; Lu, L.; Ding, H.; Chen, X.; Tang, L.; Xu, X.; Liu, G.; Hu, Y.; Ma, Y.; et al. Effects of Genetic and Nongenetic Factors on Total and Bioavailable 25(OH)D Responses to Vitamin D Supplementation. J. Clin. Endocrinol. Metab. 2017, 102, 100–110. [Google Scholar] [CrossRef]
  30. Jiang, W.; Wu, D.B.; Xiao, G.B.; Ding, B.; Chen, E.Q. An epidemiology survey of vitamin D deficiency and its influencing factors. Med. Clin. 2020, 154, 7–12. [Google Scholar] [CrossRef]
  31. Li, R.; Li, W.; Lun, Z.; Zhang, H.; Sun, Z.; Kanu, J.S.; Qiu, S.; Cheng, Y.; Liu, Y. Prevalence of metabolic syndrome in Mainland China: A meta-analysis of published studies. BMC Public Health 2016, 16, 296. [Google Scholar] [CrossRef] [Green Version]
  32. McCracken, E.; Monaghan, M.; Sreenivasan, S. Pathophysiology of the metabolic syndrome. Clin. Dermatol. 2018, 36, 14–20. [Google Scholar] [CrossRef]
  33. Xu, H.; Li, X.; Adams, H.; Kubena, K.; Guo, S. Etiology of Metabolic Syndrome and Dietary Intervention. Int. J. Mol. Sci. 2018, 20, 128. [Google Scholar] [CrossRef] [Green Version]
  34. Melguizo-Rodriguez, L.; Costela-Ruiz, V.J.; Garcia-Recio, E.; De Luna-Bertos, E.; Ruiz, C.; Illescas-Montes, R. Role of Vitamin D in the Metabolic Syndrome. Nutrients 2021, 13, 830. [Google Scholar] [CrossRef]
  35. Bornstedt, M.E.; Gjerlaugsen, N.; Pepaj, M.; Bredahl, M.K.L.; Thorsby, P.M. Vitamin D Increases Glucose Stimulated Insulin Secretion from Insulin Producing Beta Cells (INS1E). Int. J. Endocrinol. Metab. 2019, 17, e74255. [Google Scholar] [CrossRef] [Green Version]
  36. Corbetta, S.; Mantovani, G.; Spada, A. Metabolic Syndrome in Parathyroid Diseases. Front. Horm. Res. 2018, 49, 67–84. [Google Scholar] [CrossRef]
  37. Prasad, G.; Bandesh, K.; Giri, A.K.; Kauser, Y.; Chanda, P.; Parekatt, V.; Mathur, S.; Madhu, S.V.; Venkatesh, P.; Bhansali, A.; et al. Genome-Wide Association Study of Metabolic Syndrome Reveals Primary Genetic Variants at CETP Locus in Indians. Biomolecules 2019, 9, 321. [Google Scholar] [CrossRef] [Green Version]
  38. Oh, J.; Barrett-Connor, E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: The Rancho Bernardo Study. Metabolism 2002, 51, 356–359. [Google Scholar] [CrossRef]
  39. Filus, A.; Trzmiel, A.; Kuliczkowska-Plaksej, J.; Tworowska, U.; Jedrzejuk, D.; Milewicz, A.; Medras, M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 2008, 11, 134–139. [Google Scholar] [CrossRef]
  40. Schuch, N.; Garcia, V.; Vívolo, S.; Martini, L. Relationship between Vitamin D Receptor gene__polymorphisms and the components of metabolic syndrome. Nutr. J. 2013, 12, 96. [Google Scholar] [CrossRef] [Green Version]
  41. Zhao, T.; Zhang, D.; Liu, Y.; Feng, M.; Xu, Z.; Huang, H.; Zhang, L.; Li, W.; Li, X. The Association Between GC Gene Polymorphisms and Metabolic Syndrome in Chinese Rural Population: A Case-Control Study. Diabetes Metab. Syndr. Obes. 2022, 15, 165–174. [Google Scholar] [CrossRef] [PubMed]
  42. Bea, J.W.; Jurutka, P.W.; Hibler, E.A.; Lance, P.; Martinez, M.E.; Roe, D.J.; Sardo Molmenti, C.L.; Thompson, P.A.; Jacobs, E.T. Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 2015, 64, 447–459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Ganji, V.; Sukik, A.; Alaayesh, H.; Rasoulinejad, H.; Shraim, M. Serum vitamin D concentrations are inversely related to prevalence of metabolic syndrome in Qatari women. Biofactors 2020, 46, 180–186. [Google Scholar] [CrossRef] [PubMed]
  44. Buchmann, N.; Eckstein, N.; Spira, D.; Demuth, I.; Steinhagen-Thiessen, E.; Norman, K. Vitamin D insufficiency is associated with metabolic syndrome independent of insulin resistance and obesity in young adults—The Berlin Aging Study II. Diabetes Metab. Res. Rev. 2021, 37, e3457. [Google Scholar] [CrossRef] [PubMed]
  45. Gagnon, C.; Lu, Z.X.; Magliano, D.J.; Dunstan, D.W.; Shaw, J.E.; Zimmet, P.Z.; Sikaris, K.; Ebeling, P.R.; Daly, R.M. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: Results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J. Clin. Endocrinol. Metab. 2012, 97, 1953–1961. [Google Scholar] [CrossRef] [Green Version]
  46. Amirbaigloo, A.; Hosseinpanah, F.; Sarvghadi, F.; Tohidi, M.; Eskandary, P.S.; Azizi, F. Absence of association between vitamin D deficiency and incident metabolic syndrome: Tehran Lipid and Glucose Study. Metab. Syndr. Relat. Disord. 2013, 11, 236–242. [Google Scholar] [CrossRef]
  47. Pham, T.M.; Ekwaru, J.P.; Setayeshgar, S.; Veugelers, P.J. The Effect of Changing Serum 25-Hydroxyvitamin D Concentrations on Metabolic Syndrome: A Longitudinal Analysis of Participants of a Preventive Health Program. Nutrients 2015, 7, 7271–7284. [Google Scholar] [CrossRef] [Green Version]
  48. Gao, Y.; Ran, X.; Ren, Y.; Chen, T.; Tian, H. Relationship between vitamin D level and the incidence of metabolic syndrome in adults in Chengdu city: A prospective cohort study. Chin. J. Evid.-Based Med. 2017, 17, 1121–1126. [Google Scholar]
  49. Khan, H.; Kunutsor, S.; Franco, O.H.; Chowdhury, R. Vitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studies. Proc. Nutr. Soc. 2013, 72, 89–97. [Google Scholar] [CrossRef]
  50. Zaidieva, Y.Z.; Balan, V.E.; Tsar’Kov, A.V. Vitamin D supplementation improves metabolic syndrome risk profile in postmenopausal women. Med. Alph. 2020, 23, 24–31. [Google Scholar] [CrossRef]
  51. Yu, S.; Song, L.; Wei, Q.; Lv, Y.; Wan, Z. Dose-response relationship between serum 25-hydroxyvitamin D and the risk of metabolic syndrome. Clin. Nutr. 2021, 40, 1530–1536. [Google Scholar] [CrossRef] [PubMed]
  52. Khayyatzadeh, S.S.; Mirmoosavi, S.J.; Fazeli, M.; Abasalti, Z.; Avan, A.; Javandoost, A.; Rahmani, F.; Tayefi, M.; Hanachi, P.; Ferns, G.A.; et al. High-dose vitamin D supplementation is associated with an improvement in several cardio-metabolic risk factors in adolescent girls: A nine-week follow-up study. Ann. Clin. Biochem. 2018, 55, 227–235. [Google Scholar] [CrossRef] [PubMed]
  53. Maroufi, N.F.; Pezeshgi, P.; Mortezania, Z.; Pourmohammad, P.; Eftekhari, R.; Moradzadeh, M.; Vahedian, V.; Nouri, M. Association between vitamin D deficiency and prevalence of metabolic syndrome in female population: A systematic review. Horm. Mol. Biol. Clin. Investig. 2020, 41. [Google Scholar] [CrossRef]
Table
Table 1. Characteristics of the studied population (medians and interquartile ranges (P25–P75)).
Table 1. Characteristics of the studied population (medians and interquartile ranges (P25–P75)).
ParametersMedian (P25–P75) or N (%)
Sociodemographic characteristics
Age (years)30.04 (23.98–37.81)
Nationality
       Han1309 (86.98)
       Ethnic minorities196 (13.02)
Education
       Primary375 (24.92)
       Medium876 (58.21)
       Advanced254 (16.88)
Area type
       Rural891 (59.20)
       Urban614 (40.80)
Latitude (°N)32.26 (27.78–38.02)
Distric
       Eastern522 (34.68)
       Central478 (31.76)
       Western505 (33.55)
Season
       Spring118 (7.84)
       Autumn774 (51.43)
       Winter613 (40.73)
Lifestyle
Cigarette current/former smoker22 (1.46)
Alcohol consumer322 (21.40)
SNP
CYP2R1 rs12794714
       AA219 (14.55)
       GA711 (47.24)
       GG575 (38.21)
GC rs2282679
       GG152 (10.10)
       GT620 (41.20)
       TT733 (48.70)
VDR rs2228570
       AA333 (22.13)
       GA748 (49.70)
       GG424 (28.17)
Table
Table 2. Clinical characteristics according to the number of MetS’s components.
Table 2. Clinical characteristics according to the number of MetS’s components.
ParametersTotal (N = 1505) MetS Components p
0 (N = 537)1–2 (N = 812)≥3 (N = 156)
Anthropometry
       BMI (kg/m2)22.67 (20.29–25.12)20. 83 (19.29–22.48) *23.50 (20.87–25.84) *26.84 (25.14–29.35) *<0.001
       WC (cm)75.40 (69.88–82.30)70.95 (66.50–74.38) *78.00 (71.89–84.00) *87.05 (83.26–91.4) *<0.001
       SBP (mmHg)115.00 (107.67–123.33)111.33 (105.67–118.67) *116.00 (108.33–123.67) *128.33 (117.67–141.50) *<0.001
       DBP (mmHg)71.33 (65.67–76.67)69.33 (64.33–74.50) *71.67 (66.00–76.67) *80.67 (72.67–89.33) *<0.001
Biochemistry
       Serum 25(OH)D (ng/mL)16.63 (11.96–22.55)17.15 (12.56–23.50) a16.19 (11.80–22.18)16.35 (11.52–22.52)0.041
       Serum PTH (pg/mL)34.21 (25.99–44.37)31.81 (24.40–41.56) *35.57 (26.70–46.13)36.39 (28.50–48.90)<0.001
       Serum Ca (mmol/L)2.26 (2.15–2.37)2.26 (2.16–2.37)2.26 (2.15–2.36)2.26 (2.14–2.40)0.510
       Serum P (mmol/L)1.35 (1.23–1.48)1.37 (1.25–1.49)1.35 (1.23–1.47)1.27 (1.15–1.46) *<0.001
       ALT (U/L)12.41 (9.00–16.31)11.53 (8.00–14.97) *12.98 (9.00–16.92) *14.64 (10.00–19.00) *<0.001
       CRE (nmol/L)76.70 (71.00–82.00)76.00 (70.99–82.81)76.00 (72.00–82.00)75.92 (70.00–81.00)0.168
       IL6 (pg/mL)1.50 (1.50–1.73)1.50 (1.50–1.61)1.50 (1.50–1.77)1.50 (1.50–1.92)0.158
       hs-CRP (mg/L)0.62 (0.21–1.44)0.39 (0.15–0.98) *0.69 (0.24–1.62) *1.14 (0.45–2.19) *<0.001
       TC (mmol/L)4.20 (3.71–4.78)4.30 (3.86–4.86)4.10 (3.56–4.68) *4.24 (3.80–4.95)<0.001
       TG (mmol/L)0.88 (0.63–1.22)0.71 (0.54–0.93) *0.94 (0.69–1.26) *1.94 (1.46–2.64) *<0.001
       LDL-C (mmol/L)2.46 (2.03–2.96)2.37 (2.00–2.82)2.46 (2.00–2.97)2.70 (2.30–3.26) *<0.001
       HDL-C (mmol/L)1.30 (1.12–1.51)1.52 (1.39–1.67) *1.18 (1.05–1.34) *1.06 (0.91–1.18) *<0.001
       FBG (mmol/L)4.88 (4.54–5.17)4.78 (4.48–5.06) *4.90 (4.56–5.19) *5.16 (4.80–5.60) *<0.001
Abbreviations: BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; 25(OH)D, 25-hydroxyvitamin D; PTH, parathyroid hormone; Ca, corrected calcium by albumin; P, phosphorus; ALT, alanine aminotransferase; CRE, creatinine; IL-6, interleukin-6; hs-CRP, high-sensitivity C-reactive protein; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose. *: compared with the other two groups; a: comparing group “0” with group ”1–2”, p < 0.05.
Table
Table 3. Relationships of vitamin D related SNPs and the MetS’s components.
Table 3. Relationships of vitamin D related SNPs and the MetS’s components.
Genotypes25(OH)D (ng/mL)BMI (kg/m2)WC (cm)SBP (mmHg)DBP (mmHg)TG (mmol/L)HDL-C (mmol/L)FBG (mmol/L)
rs12794714AA (N = 219)15.47 (11.82~20.41)22.30 (20.39~24.77)75.10 (70.05~80.25)115.00 (107.00~123.67)70.67 (65.00~77.00)0.89 (0.67~1.25)1.26 (1.09~1.50)4.87 (4.50~5.14)
GA (N = 711)16.68 (12.07~21.92)22.63 (20.09~25.35)75.05 (68.08~82.50)114.67 (107.67~123.33)71.67 (65.67~76.67)0.86 (0.62~1.22)1.30 (1.12~1.51)4.90 (4.56~5.19)
GG (N = 575)16.90 (11.87~24.02)22.89 (20.52~25.11)76.50 (70.50~82.70)115.67 (107.67~123.33)71.00 (65.67~76.67)0.90 (0.63~1.22)1.32 (1.13~1.53)4.86 (4.52~5.17)
p0.0650.2390.2010.7950.6830.7440.3760.224
rs2282679GG (N = 152)14.11 (10.68~18.91)22.95 (20.02~25.50)75.20 (68.29~83.05)115.17 (109.42~123.25)73.00 (65.67~77.67)0.92 (0.63~1.28)1.27 (1.12~1.48)4.90 (4.56~5.19)
GT (N = 620)16.14 (11.87~21.15)22.70 (20.49~25.13)76.00 (70.24~83.00)115.00 (107.67~124.00)71.67 (66.00~77.67)0.89 (0.64~1.24)1.30 (1.11~1.50)4.92 (4.57~5.21)
TT (N = 733)17.73 (12.54~23.89)22.49 (20.26~25.08)75.05 (69.15~81.62)114.67 (107.00~122.83)70.67 (65.00~76.00)0.87 (0.62~1.21)1.32 (1.12~1.53)4.86 (4.51~5.12)
p<0.0010.5790.1090.44700.0170.4300.1090.012
rs2228570AA (N = 333)17.14 (12.48~23.72)22.46 (20.16~25.11)74.10 (69.02~81.02)113.67 (107.17~123.33)71.67 (65.33~77.00)0.90 (0.63~1.22)1.32 (1.11~1.50)4.88 (4.52~5.17)
GA (N = 748)16.93 (12.31~22.47)22.84 (20.27~25.30)75.68 (69.50~82.64)115.00 (107.33~123.67)71.17 (65.67~76.67)0.87 (0.62~1.24)1.32 (1.13~1.52)4.88 (4.55~5.20)
GG (N = 424)15.38 (11.47~21.56)22.44 (20.45~24.94)76.15 (70.10~82.74)116.00 (108.00~123.33)71.00 (65.33~77.00)0.89 (0.65~1.21)1.28 (1.10~1.50)4.87 (4.52~5.14)
p0.0100.6440.0700.4140.9200.9830.3780.559
GRS0–1 (N = 333)18.28 (12.62~25.08)22.47 (20.25~25.33)75.00 (69.02~81.38)114.67 (106.67~122.83)70.67 (65.00~76.67)0.88 (0.62~1.17)1.36 (1.14~1.57)4.86 (4.55~5.15)
2–3 (N = 900)16.72 (12.02~22.30)22.78 (20.32~25.14)75.42 (70.00~82.46)115.00 (108.00~123.33)71.67 (66.00~76.67)0.88 (0.62~1.24)1.30 (21.11~1.49)4.88 (4.54~5.18)
4–6 (N = 272)14.68 (10.97~20.20)22.41 (20.25~24.93)76.28 (70.05~83.00)115.67 (107.33~123.67)70.83 (65.00~78.33)0.89 (0.67~1.20)1.26 (1.10~1.52)4.90 (4.55~5.18)
p<0.0010.6920.3800.3810.3880.7100.0030.570
Abbreviations: GRS, genetic risk score; 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose.
Table
Table 4. Generalized linear model of the associations between serum 25(OH)D and related factors.
Table 4. Generalized linear model of the associations between serum 25(OH)D and related factors.
Parametersβ95%CIp
LowerUpper
Season
       Spring−0.061−1.2111.0880.917
       Autumn2.4841.8673.101<0.001
       Winter0
Area type
       Rural2.0561.4622.650<0.001
       Urban0
District
       Eastern2.3811.6393.123<0.001
       Central2.1421.3762.908<0.001
       Western0
Education
       Primary0.031−1.7801.8430.973
       Medium0.310−0.4831.1040.443
       Advanced0
Nationality
       Ethnic minorities0.591−0.3581.5400.222
       Han0
Cigarette smoker
       No1.817−0.6334.2680.146
       Yes0
Alcohol consumer
       No−0.088−1.8781.7030.923
       Yes0
GRS
       0–12.6351.7253.546<0.001
       2–31.3440.5772.1100.001
       4–60
Latitude (°N)−0.562−0.605−0.519<0.001
Age (years)0.0680.0280.1080.001
BMI (kg/m2)0.1120.0030.2210.044
Serum PTH (pg/mL)−0.046−0.063−0.028<0.001
Serum Ca (mmol/L)0.367−1.0721.8060.617
Serum P (mmol/L)0.571−0.6631.8050.365
ALT (U/L)0.007−0.0230.0370.644
CRE (nmol/L)0.0840.0550.114<0.001
IL6 (pg/mL)−0.157−0.304−0.0110.035
hs-CRP (mg/L)0.1810.0480.3150.008
WC (cm)0.003−0.0260.0320.825
TC (mmol/L)2.167−0.2164.5500.075
TG (mmol/L)−0.09−0.6340.4530.744
LDL-C (mmol/L)−1.936−4.4040.5330.124
HDL-C (mmol/L)−0.381−2.962.1970.772
SBP (mmHg)0.003−0.0290.0340.874
DBP (mmHg)−0.012−0.0580.0340.608
FBG (mmol/L)0.5590.1240.9950.012
Abbreviations: GRS, genetic risk score; BMI, body mass index; PTH, parathyroid hormone; Ca, calcium; P, phosphorus; ALT, alanine aminotransferase; CRE, creatinine; IL-6, interleukin-6; hs-CRP, high-sensitivity C-reactive protein; WC, waist circumference; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose.
Table
Table 5. The relationships of BMI, MetS, MetS’s components, and vitamin D insufficiency.
Table 5. The relationships of BMI, MetS, MetS’s components, and vitamin D insufficiency.
ParametersN (%)Prevalence of Vitamin D Insufficiency, N (%)χ2p
BMI 0.7150.870
       Underweight136 (9.04)48 (35.29)
       Normal weight837 (55.61)314 (37.51)
       Overweight379 (25.18)148 (39.05)
       Obese153 (10.17)56 (36.60)
MetS 3.2230.073
       Yes358 (23.79)149 (41.62)
       No1147 (76.21)417 (36.36)
Elevated Waist 2.8840.089
       Yes492 (32.69)200 (40.65)
       No1013 (67.31)366 (36.13)
Elevated TG 5.9210.015
       Yes186 (12.36)85 (45.70)
       No1319 (87.64)481(36.47)
Reduced HDL-C 16.160<0.001
       Yes716 (47.57)307 (42.88)
       No789 (53.43)259 (32.83)
Hypertension 0.0180.892
       Yes102 (6.78)39 (38.24)
       No1403 (93.22)527 (37.56)
Hyperglycemia 4.2400.039
       Yes91 (6.05)25 (27.47)
       No1414 (93.95)541 (38.26)
All1505 (100)566 (37.61)
Abbreviations: BMI, body mass index; MetS, metabolic syndrome; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol.
Table
Table 6. Odds ratios for MetS and its components according to vitamin D status.
Table 6. Odds ratios for MetS and its components according to vitamin D status.
Index <14.22 ng/mL (N = 566) 14.22–18.06 ng/mL
(N = 288)		 ≥18.06 ng/mL (N = 651)
βOR (95%CI)p1βOR (95%CI)p2
MetSCrude #0.2441.276 (0.912~1.786)0.15510.0321.033 (0.739~1.443)0.851
Adjusted a0.4271.533 (0.980~2.399)0.06210.3311.393 (0.874~2.219)0.163
Adjusted b0.4131.511 (0.964~2.368)0.07210.3411.406 (0.882~2.242)0.152
Elevated WaistCrude #0.2001.222 (0.902~1.655)0.19610.0131.013 (0.751~1.368)0.932
Adjusted a0.4771.612 (1.014~2.561)0.04310.3841.467 (0.910~2.367)0.116
Adjusted b0.4821.620 (1.018~2.578)0.04210.4031.496 (0.926~2.416)0.100
Elevated TGCrude #0.7592.137 (1.306~3.495)0.00210.5131.670 (1.019~2.738)0.042
Adjusted a0.7932.210 (1.318~3.706)0.00310.4641.590 (0.936~2.703)0.087
Adjusted b0.7842.190 (1.304~3.678)0.00310.4871.627 (0.956~2.769)0.073
Reduced HDL-CCrude #0.4211.524 (1.145~2.028)0.0041−0.0110.989 (0.748~1.308)0.937
Adjusted a0.4941.639 (1.206~2.229)0.00210.0261.026 (0.752~1.399)0.872
Adjusted b0.4811.617 (1.188~2.202)0.00210.0611.063 (0.779~1.452)0.700
HypertensionCrude #0.3701.448 (0.773~2.714)0.24810.4661.593 (0.865~2.934)0.135
Adjusted a0.4101.506 (0.767~2.959)0.23410.2371.267 (0.635~2.527)0.502
Adjusted b0.3561.428 (0.723~2.819)0.30510.2341.263 (0.632~2.524)0.508
HyperglycemiaCrude #−0.5320.588 (0.323~1.069)0.08210.4661.593 (0.865~2.934)0.135
Adjusted a−0.5280.590 (0.314~1.108)0.10110.0431.044 (0.570~1.912)0.889
Adjusted b−0.5460.579 (0.308~1.091)0.09110.0621.064 (0.580~1.953)0.841
Abbreviations: β, beta coefficients; MetS, metabolic syndrome; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol. # Crude: unadjusted. a Adjusted: season, district, area type, latitude, age, BMI, PTH, P, ALT, CRE, IL-6 and hs-CRP. b Adjusted: season, district, area type, latitude, age, BMI, PTH, P, ALT, CRE, IL-6, hs-CRP and GRS.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shan, X.; Zhao, X.; Li, S.; Song, P.; Man, Q.; Liu, Z.; Hu, Y.; Yang, L. Association of Serum 25(OH)D with Metabolic Syndrome in Chinese Women of Childbearing Age. Nutrients 2022, 14, 2301. https://doi.org/10.3390/nu14112301

AMA Style

Shan X, Zhao X, Li S, Song P, Man Q, Liu Z, Hu Y, Yang L. Association of Serum 25(OH)D with Metabolic Syndrome in Chinese Women of Childbearing Age. Nutrients. 2022; 14(11):2301. https://doi.org/10.3390/nu14112301

Chicago/Turabian Style

Shan, Xiaoyun, Xiayu Zhao, Siran Li, Pengkun Song, Qingqing Man, Zhen Liu, Yichun Hu, and Lichen Yang. 2022. "Association of Serum 25(OH)D with Metabolic Syndrome in Chinese Women of Childbearing Age" Nutrients 14, no. 11: 2301. https://doi.org/10.3390/nu14112301

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop